{
    "patient": {
        "Name": "Michael Schmidt",
        "DateOfBirth": "1992-05-25",
        "Sex": "Male",
        "Diagnosis": "Acinar cell carcinoma",
        "BodyPart": "Pancreatic",
        "Physician": "Dr. Jerome House",
        "TreatingInstitution": "Schmidt, Gutierrez and Lynch"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Pancreatic",
            "CollectedDate": "2023-07-03",
            "ReceivedDate": "2023-07-03",
            "TumorPercentage": "60%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-07-10",
            "ReceivedDate": "2023-07-15"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "MSH2",
                "DNA Alteration": "c.1906G>C",
                "GeneMutation": "p.A636P Nonsense-LOF",
                "VariantAlleleFraction": "3.22%"
            },
            {
                "Gene": "PTEN",
                "DNA Alteration": "c.389G>C",
                "GeneMutation": "p.R130Q Spliceregionvariant-GOF",
                "VariantAlleleFraction": "12.8%"
            },
            {
                "Gene": "U2AF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.S34X Spliceregionvariant-GOF",
                "VariantAlleleFraction": "29.63%"
            },
            {
                "Gene": "HRAS",
                "DNA Alteration": "c.35G>A",
                "GeneMutation": "p.G12D Nonsense-GOF",
                "VariantAlleleFraction": "18.37%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G12X Spliceregionvariant-GOF",
                "VariantAlleleFraction": "4.75%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "DICER1",
            "STAG2"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "3 m/Mb",
            "Tmbpercentile": "90%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Equivocal"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}